On 28 December 2011 SEBI passed interim orders against seven recently listed IPOs and barred more than 100 entities from the market: issuers, promoters, directors, merchant bankers and market operators. Its probe began after wide price swings on listing.
One of the seven was Onelife Capital Advisors, which raised Rs 36.85 crore in its 2011 IPO. SEBI found that Rs 35.25 crore, about 95% of the money raised, had been diverted to three other companies, in amounts of about Rs 15.5 crore, Rs 12 crore and Rs 7.7 crore, instead of being used for the objects stated in the offer document. SEBI ordered the money brought back, and in 2014 imposed a Rs 3.5 crore penalty on the company and two executives.
Rs 35.25 crore diverted of Rs 36.85 crore raised
Interim orders are preliminary, and outcomes differed by company. SEBI later barred Brooks Laboratories and its top executives from the capital market for five years.
What anyone can check today:
- Before an IPO: the "objects of the issue" section of the offer document says what the money is for, and how much is left as general corporate purposes.
- After listing: issues above a size threshold must appoint a monitoring agency, and its reports say whether the money was used as promised.
Sources: SEBI interim orders of 28 December 2011, as reported by Business Standard; SEBI order on Onelife Capital Advisors, as reported by Governance Now; Business Standard, November 2014, on the Rs 3.5 crore penalty. Information only. Not investment advice. Not a SEBI-registered research analyst.